首页> Cancer biology & therapy> Ki-67 index as a prognostic factor of subsequent lapatinib-based therapy in HER2-positive metastatic breast cancer with resistance to trastuzumab

Ki-67 index as a prognostic factor of subsequent lapatinib-based therapy in HER2-positive metastatic breast cancer with resistance to trastuzumab

导出原文传递

翻译打印收藏纠错

第一作者： Bian,L.

作者： Bian,L. ^[1] ; Wang,T. ; Zhang,S.-H. ; Zhang,H.-Q. ; Guo,Y.-F. ; Du,G. ; Li,W. ; Wu,S.-K. ; Song,S.-T. ; Jiang,Z.-F.

作者单位： Department of Breast Cancer, Affiliated Hospital of Academy of Military Medical Sciences, Beijing ^[1]

关键词 HER2 positive Ki-67 Lapatinib Metastatic breast cancer Prognostic factor Resistance Trastuzumab

发布时间 2015-03-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cancer biology & therapy

2014年15卷4期

365-370页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

Cancer biology & therapy

2014年15卷4期

365-370页

检索历史清除

Ki-67 index as a prognostic factor of subsequent lapatinib-based therapy in HER2-positive metastatic breast cancer with resistance to trastuzumab

Cancer biology & therapy

相似文献

同项目论文

Cancer biology & therapy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Ki-67 index as a prognostic factor of subsequent lapatinib-based therapy in HER2-positive metastatic breast cancer with resistance to trastuzumab

Cancer biology & therapy

相似文献

同项目论文

Cancer biology & therapy

相关期刊

检索历史清除